• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Events
  • Education
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Strong warnings issued against unapproved antibody tests

20th April 2020 by PIP editor Leave a Comment

 

Professor John Newton, the national coordinator of the UK coronavirus testing programme, has warned against the purchase of unapproved antibody testing kits.

 

Professor John Newton has warned that unapproved tests could be misleading, by providing inaccurate or inconsistent results, potentially putting those tested and those around them at risk.

 

The government has said that it is currently working with several companies who are offering these tests and are evaluating their effectiveness. However, so far, the antibody tests that have gone through the validation process have not proven accurate enough to be rolled out for public use, which is why the government has said that it is backing industry efforts to develop a homegrown test.

 

Professor John Newton, the National Coordinator of the UK Coronavirus Testing Programme, said:

 

“The government, supported by world-leading experts and regulators, is continuing to work hard to rapidly deliver a reliable and accurate back-to-work antibody testing kit, to counter the spread of the virus and enable people to return to work safely. We are breaking new ground with this work every day and I am confident this major research effort will make a breakthrough. Until then, please don’t buy or take any unproven tests. They may not be reliable for your intended use; they may give a false reading and put you, your family or others at risk.

 

“Testing is an important part of our war against coronavirus. At the moment we have swab testing that can tell you if you currently have coronavirus – for these tests a swab sample is taken and analysed in a lab. These tests are available to people in clinical need and we are also providing them to more and more key frontline workers such as NHS staff and care workers, so that they can stop self-isolating and return to work if the test comes back negative.

 

“There is another kind of test, an antibody test, which is a blood test designed to tell whether people have already had the virus and are now immune. We know they work best around a month after someone has had the virus. These could maybe be done at home with a finger prick, and deliver results in as little as 20 minutes. Such a test could, if developed in such a way that they could be reliably used at home and be sufficiently accurate, be a game-changer.

 

“Right now, however, these antibody tests are brand new and still in development. No country in the world has yet found an antibody test reliable enough to work as a back-to-work diagnostic, but the UK is leading the way in this emerging area of science and technology, and companies and scientists are doing everything they can to improve the accuracy of the tests on the market. As soon as we have found a test that works for this purpose, we will be in a position to roll them out across the country as a back-to-work test.

 

“In the meantime, I advise organisations, both in the public and private sector, against the use of antibody tests that have not been verified in a laboratory setting: and none have. The results of an inaccurate test are potentially misleading and can put people at risk of contracting the disease and transmitting it to others. The Chief Medical Officer has also said he strongly discourages the use of unvalidated tests and that, for now, the social distancing guidelines continue apply to everyone.”

 

 

This circular is being shared under the Open Government Copyright licence.

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  GPhC publish new pharmacist education and training standards

Filed Under: COVID-19, News Tagged With: Testing

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Is a pharmacist who sells rapid antibody tests unfit to practise?

Admiration for community pharmacy in Scotland

Pharmacists should follow Canada and be able to change prescriptions

No national Scottish pharmacy flu service a missed opportunity

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.